Evidence map›Paper›PMID 38385281›Full record

ArticleHaematologica2024

Gaia Martire, Federica Lovisa, Elisa Carraro, Domenico Rizzato, Simone Cesaro, Rosa Maria Mura, Annalisa Tondo, Cinzia Bertolin, Francesca Boaretto, Leonardo Salviati and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  6. Review
  7. Haematologica · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gaia MartireIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
Federica LovisaIstituto di Ricerca Pediatrica Città della Speranza, Padova.
Elisa CarraroPaediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
Domenico RizzatoIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
Simone CesaroPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona.
Rosa Maria MuraPaediatric Hematology and Oncology Unit, Ospedale Pediatrico Microcitemico, Cagliari.
Annalisa TondoDepartment of Hematology-Oncology, Anna Meyer Children's Hospital Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Firenze.
Cinzia BertolinIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
Francesca BoarettoIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
Leonardo SalviatiIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Clinical Genetics Unit, Department of Women's and Children's Health, University of Padova, Padova.
Alessandra BiffiIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
Marta PillonPaediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova.
Lara MussolinIstituto di Ricerca Pediatrica Città della Speranza, Padova, Italy; Paediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, Padova University and University Hospital, Padova. lara.mussolin@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Burkitt LymphomaMutationRituximabTumor Suppressor Protein p53AdolescentAntineoplastic Combined Chemotherapy ProtocolsChildChild, PreschoolFemaleHumansMalePrognosisRituximabTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID38385281
PMCPMC11367192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.